Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
An Bras Dermatol ; 94(2): 239-241, 2019.
Article in English | MEDLINE | ID: mdl-31090836

ABSTRACT

Atypical fibroxanthoma is a rare superficial fibrohistiocytic tumor. Clinically, it presents itself as a painless, solitary, ulcerated, and slow-growing nodule found mainly on sun-exposed areas - especially of the head and neck - of elderly individuals. The diagnosis is based on histopathological and immunohistochemical features. Immunohistochemical staining plays a critical role for the exclusion of differential diagnoses. Since atypical fibroxanthoma has an indolent clinical course, surgical excision is adequate for treatment. We present a case of atypical fibroxanthoma on the ear of a patient.


Subject(s)
Histiocytoma, Benign Fibrous/diagnosis , Skin Neoplasms/diagnosis , Aged , Diagnosis, Differential , Ear , Histiocytoma, Benign Fibrous/pathology , Humans , Immunohistochemistry , Male , Skin Neoplasms/pathology
2.
An. bras. dermatol ; 94(2): 239-241, Mar.-Apr. 2019. graf
Article in English | LILACS | ID: biblio-1001133

ABSTRACT

Abstract Atypical fibroxanthoma is a rare superficial fibrohistiocytic tumor. Clinically, it presents itself as a painless, solitary, ulcerated, and slow-growing nodule found mainly on sun-exposed areas - especially of the head and neck - of elderly individuals. The diagnosis is based on histopathological and immunohistochemical features. Immunohistochemical staining plays a critical role for the exclusion of differential diagnoses. Since atypical fibroxanthoma has an indolent clinical course, surgical excision is adequate for treatment. We present a case of atypical fibroxanthoma on the ear of a patient.


Subject(s)
Humans , Male , Aged , Skin Neoplasms/diagnosis , Histiocytoma, Benign Fibrous/diagnosis , Skin Neoplasms/pathology , Immunohistochemistry , Histiocytoma, Benign Fibrous/pathology , Diagnosis, Differential , Ear
3.
Indian J Pathol Microbiol ; 62(1): 31-35, 2019.
Article in English | MEDLINE | ID: mdl-30706856

ABSTRACT

CONTEXT: There is a correlation between prognosis of the colorectal carcinomas and the number of retrieved and metastatic lymph nodes (LNs) from mesentery/mesorectal region. At least 12 LNs must be sampled for accurate evaluation of patients. A number of factors related to surgeon, pathologist, patient and disease could affect the total LN number. For maximizing LN yield, pathologist can use ancillary methods, as fat clearance and special solutions. AIMS: This study investigates the effect of second evaluation after ethanol fixation on total and metastatic LN number and assesses factors that influence the dissected LN number. MATERIALS AND METHODS: 177 colorectal resections were refixed with ethanol for a night, after standard LN sampling. Mesentery/mesorectal tissue was reevaluated for missed LNs. Results were statistically analyzed, P values <0.05 were considered significant. RESULTS: Mean LN number increased from 26 to 30 (median: 20 to 25, P < 0.001) after ethanol fixation. Fourteen cases had additional metastatic LNs after reevaluation of the fat tissue and 5 of them upstaged. 22.5% (44/177) of the patients had <12 LNs before ethanol fixation and this decreased to 14.3% (26/177) after ethanol fixation. Resection type and length, tumor localization, size and histologic degree, pT and neoadjuvant therapy (P < 0.001) had an impact on the LN number (P = 0.034 for histologic degree, P = 0.02 for pT, P < 0.001 for others). CONCLUSIONS: Carrying out a second evaluation with ethanol fixation increased total and metastatic LN number and could lead upstage of pN. Ethanol fixation is cost-effective, easy accessible and applicable method; it may improve accuracy of LN assessment and staging, which are important for patients' outcome.


Subject(s)
Colorectal Neoplasms/diagnosis , Lymph Nodes/pathology , Lymphatic Metastasis/diagnosis , Mesentery/cytology , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/pathology , Ethanol , Female , Histological Techniques , Humans , Lymph Node Excision , Lymphatic Metastasis/pathology , Male , Mesentery/pathology , Middle Aged , Prognosis
4.
Turk Patoloji Derg ; 33(2): 134-143, 2017.
Article in English | MEDLINE | ID: mdl-28272675

ABSTRACT

OBJECTIVE: There is no other screening program close to the success rate of PAP test. Cervical cytology constitutes a large workload so that quality control in cervical cytology is important for the quality assurance of pathology laboratories. MATERIAL AND METHOD: In this study, we collected the cervical cytology results from all over Turkey and discussed the parameters influencing the quality of the PAP test. The study was conducted with Turkish gynaecopathology working group and 38 centers (totally 45 hospitals) agreed to contribute from 24 different cities. The study was designed to cover the cervical cytology results during 2013. The results were evaluated from the data based on an online questionnaire. RESULTS: The total number of Epithelial Cell Abnormality was 18,020 and the global Epithelial Cell Abnormality rate was 5.08% in the total 354,725 smears and ranging between 0.3% to 16.64% among centers. The Atypical squamous cells /Squamous intraepithelial lesion ratios changed within the range of 0.21-13.94 with an average of 2.61. When the centers were asked whether they performed quality assurance studies, only 14 out of 28 centers, which shared the information, had such a control study and some quality parameters were better in these centers. CONCLUSION: There is an increase in the global Epithelial Cell Abnormality rate and there are great differences among centers. Quality control studies including the Atypical squamous cells/Squamous intraepithelial lesion ratio are important. Corrective and preventive action according to quality control parameters is a must. A cervical cytology subspecialist in every center can be utopic but a dedicated pathologist in the center is certainly needed.


Subject(s)
Early Detection of Cancer/standards , Medical Oncology/standards , Quality Control , Uterine Cervical Neoplasms/epidemiology , Vaginal Smears/standards , Female , Humans , Turkey/epidemiology , Uterine Cervical Neoplasms/diagnosis
5.
Turk Patoloji Derg ; 29(3): 179-84, 2013.
Article in English | MEDLINE | ID: mdl-24022307

ABSTRACT

OBJECTIVE: Cervical carcinoma has been included in the preventable diseases category ever since the use of cervical cytology in routine practice. The Pap test is an efficient screening test. We aimed to compare the cervical cytology diagnosis with biopsy and smear follow up results in our institution. MATERIAL AND METHOD: We aimed to compare the diagnosis of cytology material examined in our institution during the 2009-2012 period with their biopsy and smear follow ups. The diagnoses were compared with the follow up smears and/or cervical biopsies. RESULTS: 13610 Pap tests were examined during September 2009-July 2012. Among these cases, there were 370 atypical squamous cells of undetermined significance (ASCUS), 29 atypical squamous cells-high grade intraepithelial lesions cannot be excluded (ASC-H), 155 low grade squamous intraepithelial lesion (LSIL), 33 high grade squamous intraepithelial lesion (HSIL), and 5 atypical glandular cell (AGC) diagnoses. The ratio of atypical squamous cell (ASCUS and ASC-H) to squamous intraepithelial lesions was 2.12. Squamous intraepithelial lesion was verified in 47 of 91 ASCUS cases. Among patients who had a cervical biopsy, 52 of 64 LSIL cases and all of the 21 HSIL cases had biopsy-proven SIL. CONCLUSION: Atypical squamous cell (ASC) is the most common diagnosis in abnormal cervical cytology. As it is indefinite, ASC is used as a quality assurance parameter and the aim is to decrease its use. As the ratio of epithelial cell abnormality is variable in different populations, the ASC/SIL is a more definite variable to be used for quality assurance. The efficiency in clinical use of the cervical cytology screening test is determined by biopsy verification. Our epithelial cell abnormality, ASC/SIL ratio and cytology-histology correlation values were parallel to the literature, proving that the methods are used reliably at our institution.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Papanicolaou Test , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Neoplasms/diagnosis , Vaginal Smears , Adolescent , Adult , Aged , Biopsy , Female , Humans , Middle Aged , Young Adult
6.
Turk Patoloji Derg ; 28(3): 251-8, 2012.
Article in English | MEDLINE | ID: mdl-23011828

ABSTRACT

OBJECTIVE: The description of Barrett's esophagus which is a risk factor for esophageal adenocarcinoma has differences, and the need of goblet cells for diagnosis is controversial. However, the pathophysiology in the metaplasia seen in Barrett's esophagus is not totally understood and new methods are searched for the assessment of progression to dysplasia. We aimed to search the immunohistochemical expression of CDX2, COX2 and MUC2 in Barrett's esophagus to detect any early evidence of intestinal metaplasia or dysplasia. MATERIAL AND METHOD: The staining properties were examined in the intestinal metaplastic (goblet cell-containing columnar epithelium), columnar (non-goblet columnar epithelium), distant columnar (non-goblet columnar epithelium distant from intestinal metaplastic epithelium) and squamous epithelium in 59 pathologically diagnosed Barrett's esophagus, 22 of which having dysplasia. The results were compared statistically with Pearson and Fisher exact tests. RESULTS: The distribution of the staining of intestinal metaplastic, non-goblet columnar distant columnar, and squamous epithelium, respectively were as follows: for CDX2 76.3%, 23.7%, 1.7%, 0%; for COX-2 93.2%, 47.5%, 8%, 62.9%; for MUC2 93.2%, 11.9%, 4% and 0%. The expression of CDX2, COX2 and MUC2 in the intestinal metaplastic epithelium was higher than the expression in distant and non-goblet columnar epithelium. The expression of CDX2, COX2 and MUC2 in the foci of dysplasia decreased significantly (18.2%, 27.3%, 31.9%, and p=0.039, 0.0001, 0.0001, respectively). COX2 expression in squamous epithelium was also lower when the adjacent mucosa has dysplasia (p=0.014). CONCLUSION: The CDX2, COX2 and MUC2 expressions were seen in the intestinal epithelium having goblet cells. The use of the markers in the diagnosis is controversial but the difference in the Barrett esophagus-dysplasia sequence seems to be meaningful.


Subject(s)
Barrett Esophagus/metabolism , Cyclooxygenase 2/biosynthesis , Goblet Cells/metabolism , Homeodomain Proteins/biosynthesis , Metaplasia/metabolism , Mucin-2/biosynthesis , Adult , Aged , Barrett Esophagus/diagnosis , Barrett Esophagus/pathology , Biomarkers, Tumor/analysis , CDX2 Transcription Factor , Cyclooxygenase 2/analysis , Disease Progression , Female , Homeodomain Proteins/analysis , Humans , Immunohistochemistry , Male , Metaplasia/diagnosis , Metaplasia/pathology , Middle Aged , Mucin-2/analysis
7.
Arch Gynecol Obstet ; 286(2): 379-84, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22410957

ABSTRACT

PURPOSE: The incidence of tuberculosis (TB) has increased worldwide in the past decade and it still remains an important global public health problem. METHOD: A retrospective clinicopathological study of 1,548 cases of female genital tuberculosis between 1940 and 2011 was conducted. RESULTS: The mean age of the cases was 29.49 years. Involvement of the endometrium was noted in 1,073, fallopian tubes in 164, cervix in 157, and 154 had multiple organ involvement. Clinically, 115 cases (7.4%) were diagnosed as having primary infertility and 12 cases (0.8%) as having secondary infertility. There was a coexistent carcinoma in 1.5% of the cases. Peritoneal tuberculosis in 21 cases and tuberculous lymphadenitis in 7 cases were seen as well. CONCLUSION: The clinicopathological criteria of female genital tuberculosis in the different organs are described, and special attention is paid to infertility associated with tuberculous lesion, and awareness of the fact that the disease is still with us is thus particularly important.


Subject(s)
Tuberculosis, Female Genital/epidemiology , Tuberculosis, Female Genital/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma/epidemiology , Carcinoma/pathology , Comorbidity , Fallopian Tube Diseases/epidemiology , Fallopian Tube Diseases/microbiology , Fallopian Tube Diseases/pathology , Female , Humans , Incidence , Infertility, Female/epidemiology , Infertility, Female/microbiology , Infertility, Female/pathology , Middle Aged , Peritonitis, Tuberculous/epidemiology , Peritonitis, Tuberculous/pathology , Prevalence , Retrospective Studies , Tuberculosis, Lymph Node/epidemiology , Tuberculosis, Lymph Node/pathology , Turkey/epidemiology , Uterine Diseases/epidemiology , Uterine Diseases/microbiology , Uterine Diseases/pathology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...